Ilmarinen Mutual Pension Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History

Ilmarinen Mutual Pension Insurance’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24,000	Closed	-$1.69M	–	296
2024 Q3	$1.69M	Hold	24,000	–	–	0.02%	242
2024 Q2	$1.98M	Sell	24,000 -13,000	-35%	-$1.08M	0.02%	231
2024 Q1	$3.23M	Hold	37,000	–	–	0.04%	194
2023 Q4	$3.57M	Sell	37,000 -12,000	-24%	-$1.06M	0.05%	199
2023 Q3	$4.34M	Hold	49,000	–	–	0.06%	174
2023 Q2	$4.25M	Hold	49,000	–	–	0.05%	193
2023 Q1	$4.76M	Hold	49,000	–	–	0.07%	163
2022 Q4	$5.07M	Sell	49,000 -21,000	-30%	-$1.97M	0.08%	155
2022 Q3	$5.93M	Hold	70,000	–	–	0.1%	121
2022 Q2	$5.8M	Hold	70,000	–	–	0.09%	133
2022 Q1	$5.4M	Hold	70,000	–	–	0.07%	150
2021 Q4	$6.18M	Hold	70,000	–	–	0.07%	134
2021 Q3	$5.41M	Hold	70,000	–	–	0.06%	145
2021 Q2	$5.84M	Hold	70,000	–	–	0.06%	139
2021 Q1	$5.29M	Hold	70,000	–	–	0.06%	146
2020 Q4	$6.14M	Buy	70,000 +35,000	+100%	+$2.77M	0.07%	127
2020 Q3	$2.66M	Buy	+35,000	New	+$3.54M	0.03%	182

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Ilmarinen Mutual Pension Insurance's BMRN Position: Q4 2024 in Review

Ilmarinen Mutual Pension Insurance sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 24,000 shares — an estimated $1.69M sold.

Ilmarinen Mutual Pension Insurance first reported a position in BMRN in Q3 2020 and held it in 17 quarters. The position peaked at $6.18M in Q4 2021. 544 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

Ilmarinen Mutual Pension Insurance reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Ilmarinen Mutual Pension Insurance sold 24,000 BioMarin Pharmaceuticals shares in Q4 2024, an estimated $1.69M.
Ilmarinen Mutual Pension Insurance first reported a position in BioMarin Pharmaceuticals in Q3 2020 and held it in 17 quarters.
Ilmarinen Mutual Pension Insurance's BioMarin Pharmaceuticals position peaked at $6.18M in Q4 2021.
544 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on Ilmarinen Mutual Pension Insurance's 13F filing for Q4 2024, filed 13 Feb 2025.